Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05885464
Title A Study Evaluating the Safety and Efficacy of BEAM-201 in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LL)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Beam Therapeutics Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Stanford University School of Medicine RECRUITING Stanford California 94304 United States Details
Colorado Blood Cancer Institute RECRUITING Denver Colorado 80218 United States Details
University of Chicago RECRUITING Chicago Illinois 60637 United States Details
The University of Kansas Cancer Center RECRUITING Fairway Kansas 66205 United States Details
Dana Farber and Boston Children's Hospital RECRUITING Boston Massachusetts 02115 United States Details
Cleveland Clinic- Taussig Cancer Center RECRUITING Cleveland Ohio 44106 United States Details
OHSU Knight Cancer Institute Hematology Oncology RECRUITING Portland Oregon 97239 United States Details
Children's Hospital of Philadelphia RECRUITING Philadelphia Pennsylvania 19104 United States Details
Sarah Cannon- TriStar Bone Marrow Transplant RECRUITING Nashville Tennessee 37203 United States Details
Methodist Hospital - Texas Transplant Institute RECRUITING San Antonio Texas 78229 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field